AIRS (AirSculpt Technologies) ROCE %: -4.17% (As of Mar. 2026)


AIRS AirSculpt Technologies Inc AIRS
73 GF Score
Price $4.55
GF Value $3.93
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is AirSculpt Technologies ROCE %?

AirSculpt Technologies AIRS -1.20% 73 ROCE % is -4.17% as of Mar. 2026. GuruFocus rates AIRS with a GF Score™ of 73/100 and a GF Value™ of $3.93 (Modestly Overvalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. AirSculpt Technologies's annualized ROCE % for the quarter that ended in Mar. 2026 was -4.17%.

AirSculpt Technologies  (NAS:AIRS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

AirSculpt Technologies ROCE % Related Terms

AirSculpt Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for AirSculpt Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AirSculpt Technologies ROCE % Chart

AirSculpt Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 8.90 -2.51 5.37 -0.86 -6.74

AirSculpt Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.53 1.80 -23.33 -2.51 -4.17
AIRS
73GF Score
AirSculpt Technologies Inc AIRS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AirSculpt Technologies ROCE % Calculation

AirSculpt Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-11.56/( ( (212.781 - 28.949) + (187.304 - 27.902) )/ 2 )
=-11.56/( (183.832+159.402)/ 2 )
=-11.56/171.617
=-6.74 %

AirSculpt Technologies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-6.656/( ( (187.304 - 27.902) + (191.999 - 32.481) )/ 2 )
=-6.656/( ( 159.402 + 159.518 )/ 2 )
=-6.656/159.46
=-4.17 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -4.17% mean?
AirSculpt Technologies (AIRS) has a ROCE % of -4.17% as of Mar. 2026.
Is AirSculpt Technologies' ROCE % too high?
AirSculpt Technologies' current ROCE % is -4.17%. Overall, AirSculpt Technologies has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AirSculpt Technologies' ROCE % compare to CYH and CCRN?
AirSculpt Technologies' ROCE % of -4.17% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AirSculpt Technologies's current ROCE % is -4.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AirSculpt Technologies stock overvalued right now?
Based on GuruFocus' analysis, AirSculpt Technologies (AIRS) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.93, compared to a current price of $4.55 — trading 15.8% above its estimated fair value. The current ROCE % is -4.17%. AirSculpt Technologies' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For AirSculpt Technologies (AIRS), the current ROCE % is -4.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AirSculpt Technologies (AIRS) Overvalued in 2026?

Based on GuruFocus' analysis, AirSculpt Technologies stock appears to be overvalued. The current stock price of $4.55 is trading 15.8% above its estimated GF Value™ of $3.93. GuruFocus considers AirSculpt Technologies to be Modestly Overvalued.

Key valuation signals for AIRS:

  • ROCE %: -4.17%
  • GF Value™: $3.93 vs. price of $4.55 (15.8% above fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the AIRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AirSculpt Technologies Business Description

Address 1111 Lincoln Road, Suite 802, Miami Beach, FL, USA, 33139
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
73GF Score

Get the complete analysis for AIRS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.55
Price
$3.93
GF Value